InsidersTradesSigma
Follow the Ajanta Pharma Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Ajanta Pharma Limited has published 229 reports. Market capitalisation: €429.3bn. The latest transaction was disclosed on 13 March 2026 (Sale). Among the most active insiders: Ravi Agrawal, Trustee Ravi Agrawal Trust. Every trade is free.
229
Insider Decl.
n/a
Thresholds
€25,087
24 ops.
Buy Volume
€90m
82 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ajanta Pharma Limited Strong Buy (bullish), based on 14 analysts. Average price target: ₹3,343.29.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,923 of 29,063 companies
61.2
score / 100
Value34
Quality88
FCF yld0.4%
Earn yld2.5%
EV/EBITDA27.6x
ROE25%
Gross mgn77%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 March 2026
Declarations229 total
607 shares@ ₹3,100.17960.0000% mcap6.7% of flowEquity SharesSEBI:09f83c50e1bac8e6003c99c5247da57a14155d52
750 shares@ ₹2,713.087.3% of flowEquity SharesSEBI:1dcb887468b5d4a74fb919411c27e99e7893a57e
2,000 shares@ ₹2,565.4118.9% of flowEquity SharesSEBI:b8a8da2a9bbe096359fd6d548efbdff8ec27f242
3,000 shares@ ₹2,528.4327.9% of flowEquity SharesSEBI:7a5683ef306d063ae8f127f6c5f38c223198f465
900 shares@ ₹2,574.438.7% of flowEquity SharesSEBI:236dcc9589a0e4d020fc29f52ef6da0a24753cc4
548 shares@ ₹2,722.4489100.0% of flowEquity SharesSEBI:ce751f9aa0fac774fd6ff216cc053d2f3eb8b27e
100 shares@ ₹3,000.008.9% of flowEquity SharesSEBI:81aaeec7dc43066be3e1e9f9ab61c9b6f3488d33
51 shares@ ₹3,100.004.5% of flowEquity SharesSEBI:e850b263b0dd81b8e4f70577e477cf6e5d5372fe
100 shares@ ₹2,950.008.8% of flowEquity SharesSEBI:63707ea004b3312b57ff88d5dab7715d4df49aee
49 shares@ ₹3,060.004.3% of flowEquity SharesSEBI:a66349f94b664e7d90294b63148de2daadf02e93
100 shares@ ₹2,895.008.6% of flowEquity SharesSEBI:8b3dfe0f8172ec65bf734b1c670522b5e8ac5e3a
5,000 shares@ ₹3,287.23100.0% of flowEquity SharesSEBI:6570272c6b41a68967d6776410445a268276c18b
1,000 shares@ ₹2.000.0% of flowEquity SharesSEBI:11ec1415cb1adfc8c0d977492e9f742ea4f15d22
6,000 shares@ ₹3,293.6237.0% of flowEquity SharesSEBI:fff1b22265f57a362728b1d5e6ead4536a9d8b10
200 shares@ ₹2,808.5316.1% of flowEquity SharesSEBI:0531eeee2c1db1c00ff80caa97ece38e38c2e597
500 shares@ ₹2.000.0% of flowEquity SharesSEBI:5cbe99ce6cbf67e25ee89b99d9323502a0a1814a
100 shares@ ₹2,991.038.4% of flowEquity SharesSEBI:c575c82d88eef26ee0b5df9f62a647a1532482ea
100 shares@ ₹3,200.009.1% of flowEquity SharesSEBI:fe16aa19b56694fbc2cab3ec627b4c1f21fbbc53
169,983 shares@ ₹3,176.103.2% of flowEquity SharesSEBI:83532c4a739214a70ac7e432bbe4217ff0c086ce
17 shares@ ₹3,176.05880.0% of flowEquity SharesSEBI:07e65346a53f5045ad84f913bbaf464b14febef1
9,000 shares@ ₹2,938.800.2% of flowEquity SharesSEBI:ae4f299e41876841684ab08e9caae416010d7d0f
2,000 shares@ ₹2,952.4659.7% of flowEquity SharesSEBI:6a957e81a17a02247d3e9d58b71dadd7cb1d6f5a
450,000 shares@ ₹2,316.007.1% of flowEquity SharesSEBI:a2d1ba2b5d42123ea599659992d05b220461695a
720 shares@ ₹2,770.00100.0% of flowEquity SharesSEBI:daf440a3739d76cc9a9a1f65b3cadd34ceaed933
76,818 shares@ ₹2,770.0049.6% of flowEquity SharesSEBI:64ac3d3b887e16a44c782267cfa2427cc0db41ac
25 of 229 declarations
关于 Ajanta Pharma Limited
Ajanta Pharma Limited 是一家印度制药公司，专门生产仿制药和保健产品。该公司在孟买证券交易所上市。